Longer TA repeat but not V89L polymorphisms in the SRD5A2 gene may confer acne risk in the Chinese population

被引:2
|
作者
Hu, Xue [1 ]
Ding, Wei [2 ]
Jin, Xinye [3 ]
Wang, Jia [4 ]
Zou, Dajin [5 ]
Chen, Yue [6 ]
机构
[1] Shidong Hosp, Dept Endocrinol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Geriatr, Shanghai, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China
[4] Gen Hosp Jinan Mil Reg Chinese Peoples Liberat Ar, Dept Endocrinol, Jinan, Shandong, Peoples R China
[5] Second Mil Med Univ, Dept Endocrinol, Changhai Hosp, 168 ChangHai Rd, Shanghai 200433, Peoples R China
[6] Shanghai Baoshan Tradit Chinese Med Integrated Ho, Dept Endocrinol, 181 YouYi Rd, Shanghai 201900, Peoples R China
来源
POSTEPY DERMATOLOGII I ALERGOLOGII | 2018年 / 35卷 / 01期
关键词
acne; SRD5A2; gene; V89L polymorphism; (TA)n repeat polymorphism; PROSTATE-CANCER RISK; STEROID; 5-ALPHA-REDUCTASE; ASSOCIATION; TYPE-2;
D O I
10.5114/ada.2018.73162
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Introduction: Several studies have reported that the V89L and TA repeat polymorphisms [(TA)n] of the SRD5A2 gene were associated with SRD5A2 activity. The activity of dihydrotestosterone, which is converted from testosterone by SRD5A2, is responsible for sebum secretion and the formation of acne. We hypothesized that abnormalities in SRD5A2 action could contribute to the formation of acne. Aim: To study whether the structural change of the SRD5A2 gene may affect the risk of acne in patients with normal serum testosterone levels. Material and methods: Genotyping of rs523349 and (TA) n of SRD5A2 was performed in 49 Chinese acne patients with significant improvements with SRD5A2 inhibitor-finasteride but normal serum testosterone levels, and in 50 healthy Chinese age-matched controls without acne. Results: There was no significant difference between the two groups in the frequencies of V and L alleles and VV, VL, and LL genotypes of V89L (chi(2) test, p > 0.5). (TA) n polymorphic repeat sites are 5 alleles (TA0, TA3, TA6, TA9, TA12) in our population. The differences in S and L allele frequencies between the two groups were statistically significant (p < 0.005). People with a longer (n >= 6) allele of the (TA) n repeat polymorphism had a higher risk of having acne than those with a shorter (n < 6) allele (OR = 3.52, 95% CI: 1.73-7.16). Conclusions: This study suggests that SRD5A2 polymorphisms might be associated with acne risk. This is the first report focusing on the Chinese population according to our knowledge. Further large sample studies may be required to confirm the association and to assess any interactions with environmental factors.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 47 条
  • [1] Longer (TA)n Repeat but Not A49T and V89L Polymorphisms in SRD5A2 Gene May Confer Prostate Cancer Risk in South Indian Men
    Rajender, Singh
    Vijayalakshmi, Krishnaswamy
    Pooja, Singh
    Madhavi, Sakhamuri
    Paul, Solomon F. D.
    Vettriselvi, V.
    Shroff, Sunil
    Singh, Lalji
    Thangaraj, Kumarasamy
    JOURNAL OF ANDROLOGY, 2009, 30 (06): : 703 - 710
  • [2] Associations between the SRD5A2 gene V89L and TA repeat polymorphisms and breast cancer risk: a meta-analysis
    Zhang, D.
    Li, Q.
    Qu, H. -C.
    Yu, T.
    Liu, Y. -R.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03): : 9004 - 9012
  • [3] Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population
    Li, ZH
    Habuchi, T
    Mitsumori, K
    Kamoto, T
    Kinoshitu, H
    Segawa, T
    Ogawa, O
    Kato, T
    JOURNAL OF UROLOGY, 2003, 169 (06): : 2378 - 2381
  • [4] V89L polymorphism of the 5α-reductase type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk
    Boger-Megiddo, Inbal
    Weiss, Noel S.
    Barnett, Matt J.
    Goodman, Gary E.
    Chen, Chu
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (02) : 286 - 291
  • [5] Micropenis and the 5α-reductase-2 (SRD5A2) gene:: Mutation and V89L polymorphism analysis in 81 Japanese patients
    Sasaki, G
    Ogata, T
    Ishii, T
    Kosaki, K
    Sato, S
    Homma, K
    Takahashi, T
    Hasegawa, T
    Matsuo, N
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07): : 3431 - 3436
  • [6] Steroid 5-alpha-reductase type 2 (SRD5A2) gene V89L polymorphism and hypospadias risk: A meta-analysis
    Zhang, K.
    Li, Y.
    Mao, Y.
    Ma, M.
    JOURNAL OF PEDIATRIC UROLOGY, 2017, 13 (06) : 630.e1 - 630.e9
  • [7] Association of V89L SRD5A2 polymorphism with craving and serum leptin levels in male alcohol addicts
    Lenz, Bernd
    Schoepp, Eva
    Mueller, Christian P.
    Bleich, Stefan
    Hillemacher, Thomas
    Kornhuber, Johannes
    PSYCHOPHARMACOLOGY, 2012, 224 (03) : 421 - 429
  • [8] Homozygous Ala65Pro Mutation with V89L Polymorphism in SRD5A2 Deficiency
    Eren, Erdal
    Edgunlu, Tuba
    Asut, Emre
    Celik, Sevim Karakas
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2016, 8 (02) : 218 - 223
  • [9] Association of missense substitution of A49T and V89L in the SRD5A2 gene with prostate cancer in Turkish patients
    Neijmann, Sebnem Tekin
    Kural, Alev
    Tinay, Ilker
    Livaoglu, Ayten
    Cevlik, Tulay
    Turkeri, Levent
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2017, 42 (01): : 37 - 43
  • [10] The SRD5A2 V89L Polymorphism Is Associated With Severity of Disease in Men With Early Onset Prostate Cancer
    Scariano, John K.
    Treat, Eric
    Alba, Frances
    Nelson, Harold
    Ness, Scott A.
    Smith, Anthony Y.
    PROSTATE, 2008, 68 (16): : 1798 - 1805